Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era

Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era

Since the development of the Radiation Therapy Oncology Group-Recursive Partitioning Analysis (RTOG-RPA) risk classes for high-grade glioma, radiation therapy in combination with temozolomide (TMZ) has become standard care. While this combination has improved survival, the prognosis remains poor in...

Full description

Bibliographic Details
Main Authors: Paravati, Anthony J., Heron, Dwight E., Landsittel, Douglas, Flickinger, John C., Mintz, Arlan, Chen, Yi-Fan, Huq, M. Saiful
Format: Online
Language:English
Published: Springer US 2010
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151374/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151374/

Similar Items